Jeffrey Levi
George Washington University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Jeffrey Levi.
American Journal of Public Health | 2010
Marsha Lillie-Blanton; Valerie E. Stone; Alison Snow Jones; Jeffrey Levi; Elizabeth T. Golub; Mardge H. Cohen; Nancy A. Hessol; Tracey E. Wilson
OBJECTIVES We examined racial/ethnic disparities in highly active antiretroviral therapy (HAART) use and whether differences are moderated by substance use or insurance status, using data from the Womens Interagency HIV Study (WIHS). METHODS Logistic regression examined HAART use in a longitudinal cohort of women for whom HAART was clinically indicated in 2005 (N = 1354). RESULTS Approximately 3 of every 10 eligible women reported not taking HAART. African American and Hispanic women were less likely than were White women to use HAART. After we adjusted for potential confounders, the higher likelihood of not using HAART persisted for African American but not for Hispanic women. Uninsured and privately insured women, regardless of race/ethnicity, were less likely than were Medicaid enrollees to use HAART. Although alcohol use was related to HAART nonuse, illicit drug use was not. CONCLUSIONS These findings suggest that expanding and improving insurance coverage should increase access to antiretroviral therapy across racial/ethnic groups, but it is not likely to eliminate the disparity in use of HAART between African American and White women with HIV/AIDS.
Clinical Infectious Diseases | 2007
Jennifer Kates; Jeffrey Levi
The Centers for Disease Control and Prevention estimates that of the approximately 1.2 million people with human immunodeficiency virus (HIV) infection or acquired immunodeficiency syndrome in the United States, approximately 500,000 are not receiving care for their disease, including approximately 250,000 who do not know they are HIV positive. Although little is known about these 2 subgroups of HIV-infected people, they are likely to be reflective of the larger population of people with HIV infection; that is, they are predominantly racial minorities, more likely to be unemployed and/or poor, and much more likely to be uninsured or dependent on public insurance programs such as Medicaid, compared with the US population overall. In addition, many persons receive a diagnosis of HIV infection late during the course of the disease, and those who are difficult to reach are less likely to receive standard-of-care antiretroviral therapy. New testing initiatives attempting to diagnose infection in persons who do not know their HIV infection status have raised important questions about the funding and program capacity of the current system to handle new patients. Given these challenges and questions, measuring the success of new testing initiatives will be critical but difficult.
BMC Public Health | 2014
Simone Pettigrew; Jean Michel Borys; Hugues Ruault du Plessis; L. Walter; Terry Huang; Jeffrey Levi; Jan Vinck
BackgroundWhile it is acknowledged that child obesity interventions should cover multiple ecological levels (downstream, midstream and upstream) to maximize their effectiveness, there is a lack of evaluation data to guide the development and implementation of such efforts. To commence addressing this knowledge gap, the present study provides process evaluation data relating to the experiences of groups implementing the EPODE approach to child obesity prevention in various locations around the world. The aim of this exploratory study was to investigate the barriers and facilitators to program implementation in program sites around the world to assist in developing strategies to enhance program outcomes.MethodsAn online survey that included open-ended questions was distributed to the 25 EPODE programs in operation at the time of the survey (May 2012). The survey items asked respondents to comment on those aspects of program implementation that they found challenging and to suggest areas for future improvement. Eighteen programs representing 14 countries responded to the request to participate in the survey, yielding a 72% response rate. The responses were analyzed via the constant comparative method using NVivo qualitative data analysis software.ResultsThe main concerns of the various EPODE programs were their ability to secure ongoing funding and their access to evidence-based intervention methods and policy advice relating to relationships with third parties. These issues were in turn impacted by other factors, including (i) access to user-friendly information relating to the range of intervention strategies available and appropriate evaluation measures; (ii) assistance with building and maintaining stakeholder relationships; and (iii) assurance of the quality, independence, and transparency of policies and practices.ConclusionsThe findings are facilitating the ongoing refinement of the EPODE approach. In particular, standardized and tailored information packages are being made available to advise program members of (i) the various evaluation methods and tools at their disposal and (ii) methods of acquiring private partner support. Overall, the study results relating to the types of issues encountered by program members are likely to be useful in guiding the future design and implementation of multi-level initiatives seeking to address other complex and intractable health-related problems.
Clinical Infectious Diseases | 2006
Jeffrey Levi; Thomas V. Inglesby
On 1 November 2005, President Bush released the National Strategy for Pandemic Influenza [1], which outlines how the United States intends to prepare for, detect, and respond to an influenza pandemic. Congress was asked to fund the plan by appropriating
Journal of Law Medicine & Ethics | 2008
Rebecca Katz; Jeffrey Levi
7.1 billion, the bulk of which would go to the US Department of Health and Human Services (DHHS) to stockpile vaccines and antiviral drugs, to accelerate the development of new vaccine technologies, and to improve disease surveillance and the nations public health infrastructure and communications.
Archive | 2012
Jeffrey Levi; Laura M. Segal; Rebecca St. Laurent; Albert Lang; Jack Rayburn
Any reformed health care system must be able to react to and mitigate the consequences of a public health emergency. This article identifies four essential components of public health emergency preparedness, and presents measures that can be taken immediately to improve our capacity to respond to emergencies.
Archive | 2008
Jeffrey Levi; Serena Vinter; Rebecca St. Laurent; Laura M. Segal
Clinical Infectious Diseases | 2006
Bruce R. Schackman; Joseph O. Merrill; Dennis McCarty; Jeffrey Levi; Christine Lubinski
American Journal of Public Health | 2002
Jeffrey Levi
Archive | 2003
Lea Nolan; Brian Kamoie; Jennel Harvey; Lissette Vaquerano; Sarah C. Blake; Satvinder Chawla; Jeffrey Levi; Sara J. Rosenbaum